Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules …

Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules ... Shire plc , the global spec...


Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules …
Shire plc , the global specialty biopharmaceutical company, today announced results from a Phase 2 signal finding study of Vyvanse [lisdexamfetamine dimesylate ] in patients who have had residual symptoms of depression following treatment with LEXAPRO for Major Depressive Disorder .
Read more on PR Newswire via Yahoo! Finance

Leave a Reply